Cisplatin combined with tiopronin or sodium thiosulfate: Cytotoxicity in vitro and antitumor activity in vivo

Anti-Cancer Drugs

Volumn 10, Issue 4, 1999, Pages 419-428

  Viale, Maurizio ^a,d   Zhang, Jin Gang ^a   Pastrone, Ilaria ^a,b   Mariggiò, Maria A ^c   Esposito, Mauro ^a   Edward Lindup, W ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Ospedale Consorziale Policlinico   (Italy)

Author keywords

Anti cancer activity; Cisplatin; Nephroprotection; Tiopronin

Indexed keywords

ANTIDOTE; CISPLATIN; SODIUM THIOSULFATE; THIOSULFATE; TIOPRONIN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; DBA MOUSE; DOSE RESPONSE; DRUG EFFECT; FEMALE; KIDNEY; LEUKEMIA P 388; MOUSE; PATHOLOGY; RAT;

ANIMALS; ANTIDOTES; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KIDNEY; LEUKEMIA P388; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RATS; THIOPRONINE; THIOSULFATES; TUMOR CELLS, CULTURED;

EID: 0033114072     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199904000-00011     Document Type: Article

References (31)

1. Sleijfer DT, Meijer S, Mulder NH. Cisplatin: a review of clinical applications and renal toxicity. Phamiaccutiscb Weekblad Scientific Edition 1985; 7: 227-37.
2. van Basten JP, Schrafford-Koops H, Sleijfer DT, Pra E, van Driel MF, Hoekstra HJ. Current concept about testicular cancer. EnrJ Snrg Oncol 1997; 23: 354-60.
3. Thigpen T, Vance R, Puneky L, Khansurt T. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Gyiiecol Oncol 1994; 55: 597-607.
4. Skinner R. Strategies to prevent nephrotoxicity of anticancer drugs. Cnir Opin Oncol 1995; 7: 310-5.
5. Esposito M, Fulco RA, Collecclii P, et al. Improved therapeutic index of cisplatin by procaine hydrochloride. / Natl Cancer Inst 1990; 8: 677-84.
6. Heidemann HT, Muller S, Mertins L, Stepan G, Hoffmann K, Ohnhaus EE. Effect of aminophylline on cisplatin neplirotoxicity in the rat. BrJ Pbamiacol 1989; 97: 313-8.
7. Sleijfer DT, Offerman JJG, Mulder NH, et al. The protective potential of the combination of verapamil and cimetidine on cisplatin-induced nephrotoxicity in man. Cancer 1987; 60: 2823-8.
8. Bird JE, Waiser MM, Quebbeman J. Protective effect of organic cation transport inhibitors on cfa-diamminedichloroplatinum(II)-induced nephrotoxicity. J Phamiacol Exp ner 1984; 231: 752-8.
9. Aamdal S, Fodstad O, Pilu A. Some procedures to reduce cis-platinum toxicity reduce antitumour activity. Cancer Treat Rev 1987; 14: 389-95.
10. Anand AJ, Bashey B. Newer insights into cisplatin nephrptoxicity. Ann Pbannacotber 1993; 27: 1519-25.
11. Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmer P. Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pbamiacol 1994; 35: 1-9.
12. Dumas M, de Gislain C, d'Athis P, et al. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum. Cancer Cbemotber Pbannacol 1989; 23: 37-40.
13. Amor B, Lery C, De Gery A. Tiopronin N-[2-mercaptopropionyl]glycin) in rheumatoid arthritis. Artb Rheum 1982; 25: 698-703.
14. Reynolds JEF, ed. Tiopronin. In: Martindale. Tlje extra pharmacopoeia, 31st edn. London: Royal Pharmaceutical Society 1996: 176l.
15. Zhang JG, Ltndup WE. Tiopronin protects against the nephrotoxicity of cisplatin in rat renal cortical slices in vitro. Toxicol Appl Phannacol 1996; 141: 425-33.
16. Zhang JG, Lindup WE. Tiopronin protects against the nephrotoxicity of cisplatin in the rat in vivo. Nannyn Schmiedeberg's Arch Phannacol 1998; 358 (suppl 2): R532, abstr P45.9.
17. Carlsson MS, Denneberg T, Emanuelsson BM, Kagefdal B, Lindgren S. Pharmacokinetics of oral Tiopronin. Enr J Clin Phannacol 1993; 45: 79-84.
18. Catino JJ, Francher DM, Schurig JE. Evaluation of cis-diamminedichloroplatinum(II) combined with metoclopramide or sodium thiosulphate on L1210 leukemia in vitro and in vivo. Cancer Chemother Phannacol 1986; 18: 1-4.
19. Fulco RA, Vannozzi M, Collecchi P, et al. Effect of normal saline on cisplatin pliarmacokinetics and antitumor activity in mice bearing P388 leukemia. Anticancer Res 1990; 10: 1603-10.
20. Hincal AA, Long DF, Repta AJ. Cisplatin stability in aqueous parenteral audRs.JParentDnigAss 1979; 33: 107-16.
21. Hussain RF, Noun AME, Oliver RTD. A new approach for measurement of cytotoxicity using colorimetric assay. J Immtmol Methods 1993; 160: 89-96.
22. Cafaggi S, Esposito M, Parodi B, et al. S)-ntliesis and antitumor activity of a new cfr-diamminepIatinum(TI) complex containing procaine hydrochloride. Anticancer Res 1992; 12: 2285-92.
23. Gao X, Fernandez-Vina M, Shumway W, Stastny P. DNA typing for class II HLA antigens with allele-specific or group-specific amplification. I. Typing for subsets of HLA-DR4. Hum Immunol 1990; 27: 40-50.
24. Coluccia M, Boccarelli A, Mariggiö MA, et al. Platinum(II) complexes containing iminoethers: a tratis platinum antitumor agent. Cbem-Biol Interact 1995; 98: 251-66.
25. Arakawa H, Iguclii T, Monta M, et al. Novel indolocarbazole compound 6-N-formyIamino-12,13-dihydro-1, l 1-dihydroxy-l 3-(β-D-gIucopyranosyi) 5H-indolo [2,3]pyrrolo-[3,4-c]carbazole-5,7(6tflione (NB-506): its potent antitumor activities in mice. Cancer Res 1995; 55: 1316-20.
26. Berembaum MC. What is synergy? Phannacol Rev 1989; 41: 93-141.
27. Abe R, Akiyoshi T, Baba T. Inactivation of cis-diamminedicliloroplatinumOl) in blood by sodium thiosulphate. Oncology 1990; 47: 65-9.
28. Aamdal S, Fodstad O, Pilu A. Sodium thiosulphate fails to increase the therapeutic index of intravenously administered cw-diamminedichloroplatinurnQI) in mice bearing murine and human tumors. Cancer Chemother Phannacol 1988; 21: 129-33.
29. Uozumi J, Ishizawa M, Iwamoto Y, Baba T. Sodium thiosulphate inhibits c&-diamminedichloroplatinum(II) activity. Cancer Chemother Phannacol 1984; 13: 825.
30. Daley-Yates PT, McBrien DCH. Cisplatin metabolites in plasma: a study of their pharmacokinetics and importance in the neplirotoxic and antitumour activity of cisplatin. Biocbem Phannacol 1984; 33: 3063-70.
31. 2+, and the hydrolysis product of cisplatin in the rat. Cancer Cbcmothcr Phanuacol 1991; 29: 29-32.